PROBLEMS OF MASS URINE SCREENING FOR MISUSED DRUGS

被引：36

作者：

MORGAN, JP

机构：

[1] CUNY MT SINAI SCH MED,DEPT MED,NEW YORK,NY 10029

[2] CUNY CITY COLL,SOPHIE DAVIS SCH BIOMED EDUC,NEW YORK,NY 10031

来源：

关键词：

D O I：

10.1080/02791072.1984.10472301

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

引用

页码：305 / 317

页数：13

共 37 条

[1] SPECIFICITY OF THE EMIT DRUG-ABUSE URINE ASSAY-METHODS
ALLEN, LV
STILES, ML
[J]. CLINICAL TOXICOLOGY, 1981, 18 (09): : 1043 - 1065
[2] ANDERSEN O, 1977, CLIN CHEM, V23, P751
[3] ENDOGENOUS LYSOZYME INACTIVATION IN EMIT-DAU ASSAYS
ARCENAL, D
OSTERLOH, J
[J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1982, 6 (06) : 312 - 313
[4] BOST RO, 1976, CLIN CHEM, V22, P789
[5] AMPHETAMINE EMIT - STRUCTURE VERSUS REACTIVITY
BUDD, RD
[J]. CLINICAL TOXICOLOGY, 1981, 18 (01): : 91 - 110
[6] BENZODIAZEPINE STRUCTURE VERSUS REACTIVITY WITH EMIT OXAZEPAM ANTIBODY
BUDD, RD
[J]. CLINICAL TOXICOLOGY, 1981, 18 (05): : 643 - 655
[7] CAPLAN V, 1981, INTRO FORENSIC TOXIC
[8] COHEN S, 1983, DRUG ABUSE ALCOHOLIS, V12, P1
[9] DELAURENTIS M, 1982, NIDA RES MONOGRAPH, V42
[10] DINOVO EC, 1976, CLIN CHEM, V22, P843